A major market correction has created much lower stock prices, and many insiders are taking advantage of this opportunity. The amount of insider buying has surged in the last few weeks. When you see insider buying at depressed prices, it often means the shares are oversold and offer great long-term value.
Some of these stocks look like good investments for the future, while others seem to be better as short-term trading opportunities. I have provided links for each stock which verify the insider buying filed with the SEC below. Here are the stocks:
ATP Oil and Gas Corp. (ATPG) is trading at $6.90. ATPG is an independent oil and gas company, based in Texas. These shares have traded in a range between $5.53 to $21.40 in the last 52 weeks. The 50-day moving average is $9.41 and the 200-day moving is $14.38. Earnings estimates for ATPG are expected to go from a loss in 2011 to a profit of $1.49 per share in 2012. The higher revenues and margins for 2012 are due to higher production coming from oil wells in the Gulf of Mexico. Insiders have been buying significant amounts of ATPG stock in recent weeks. In mid-November, one director bought 100,000 shares and the CEO bought 65,000 shares. This stock is heavily shorted, and any good news could cause a major rally.
Blue Nile, Inc. (NASDAQ:NILE) shares are trading at $32.48. Blue Nile is an online retailer of jewelry. The shares have traded in a range between $30.32 to $64.45 in the past 52 weeks. The 50-day moving average is $39.17 and the 200-day moving average is $45.52. Earnings estimates for NILE are 92 cents per share in 2011, and $1.08 for 2012. Analysts are expecting revenues of about $360 million for 2011, and $388 million for 2012. That's only about 8% more, and that rate is not high enough to justify the current PE ratio of nearly 35 times earnings. Because of that valuation and low growth rate, I still think this stock is too expensive but insiders seem to disagree. A director just bought 15,000 and shares and not long ago the the CEO bought 10,000 shares.
Green Mountain Coffee Roasters, Inc. (NASDAQ:GMCR) shares are trading at $50.45. GMCR provides specialty coffee products. The shares have traded in a range between $31.21 to $115.98 in the past 52 weeks. The 50-day moving average is $81.44 and the 200-day moving average is $77.17. Earnings estimates for GMCR are $2.59 per share in 2011, and $3.64 for 2012. Green Mountain was a favorite stock for momentum traders and it clearly became overvalued. Recently the stock has dropped sharply due to concerns over accounting and other issues. It has become a battleground stock with shorts and longs showing major differences in their beliefs. I don't think battleground stocks are worth the risk in most cases, but the falling stock price has attracted insiders. A director recently bought 4,000 shares.
Sequenom, Inc. (NASDAQ:SQNM) is trading around $4.59. Sequenom is a biotechnology company focused on diagnostic testing. The 50-day moving average is $4.96 and the 200-day moving average is $6.63. These shares have traded in a range between $4 to $8.71 in the last 52 weeks. SQNM recently announced plans to sell a test for Down Syndrome, and that cause a brief spike in the stock. Oppenheimer set an outperform rating and a $9 price target for SQNM shares. This company has a solid balance sheet with about $100 million in cash and only around $12 million in debt. With the stock trading for about 50% of the 52 week high, this could be a good candidate for a rebound in January after all the tax-loss selling ends. The CEO just bought 50,000 shares and 3 directors recently bought shares as well.
Biosante Pharmaceuticals, Inc. (BPAX) is trading around $2.35. Biosante is a biotechnology company, based in Illinois. These shares have traded in a 52 week range between $1.40 to $4.02. The 50-day moving average is $2.48 and the 200-day moving average is $2.49. BPAX has a licensing agreement with Teva Pharmaceuticals (NYSE:TEVA) for Bio-T-Gel which treats low testosterone levels. BPAX shares are acting relatively strong, in the face of very weak markets. BPAX looks like a solibuying repeatedly this yeard buy on dips. A director recently bought 3,000 shares and other insiders have been buying repeatedly this year.
Royal Caribbean Cruises (NYSE:RCL) shares are trading at $26.08. RCL is a major cruise line company, based in Miami. The 50-day moving average is $25.49 and the 200-day moving average is $33.94. The shares have traded in a range between $18.70 to $49.99 in the past 52 weeks. Earnings estimates for RCL are for a profit of $2.77 per share in 2011 and $3.14 in 2012. RCL is facing a number of challenges, including rising oil prices, and the possibility that a slower global economy will reduce bookings. Those concerns appear to be priced in, and the stock looks cheap. A director recently bought 650 shares.
Data is sourced from Yahoo Finance and Insidercow.com.
Disclosure: I am long RCL, ATPG.
Disclaimer: The information and data is believed to be accurate, but no guarantees or representations are made. Rougemont is not a registered investment advisor and does not provide specific investment advice. The information contained herein is for informational purposes only.